Relative Bioavailability and Food Effect Study of CVN424
Status:
Completed
Trial end date:
2022-11-21
Target enrollment:
Participant gender:
Summary
This is a Randomized, Open-Label, Single Oral Dose, Three-Way Cross-Over Trial to Evaluate
the Relative Bioavailability of CVN424 Suspension and Tablet Formulations in Healthy
Volunteers Under Fasted and Fed Conditions.